Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor
Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
Breakthrough: New Drug Target for Pancreatic Cancer Spread
Research & Development Breakthrough: New Drug Target for Pancreatic Cancer Spread

Pancreatic cancer remains one of the most devastating diagnoses a patient can receive, with survival rates that have barely improved in decades and a prognosis that often leaves little room for hope. Among the various forms of this disease, pancreatic ductal adenocarcinoma (PDAC) stands out as the

Ambulatory EHR Market to Reach $10.5B by 2032 with 6.3% CAGR
Tech & Innovation Ambulatory EHR Market to Reach $10.5B by 2032 with 6.3% CAGR

In the rapidly evolving landscape of healthcare technology, the ambulatory Electronic Health Record (EHR) market stands out as a pivotal force transforming outpatient care. These digital systems, tailored for settings like physician offices and specialty clinics, manage critical tasks such as

Does Even Moderate Drinking Increase Dementia Risk?
Research & Development Does Even Moderate Drinking Increase Dementia Risk?

The conversation surrounding alcohol’s impact on health has taken a dramatic turn with emerging research that questions long-held beliefs about its safety, particularly when it comes to brain health, and a recent study published in BMJ Evidence-Based Medicine has stirred significant debate by

FTC Urged to Probe Deceptive Telehealth Weight-Loss Drug Ads
Tech & Innovation FTC Urged to Probe Deceptive Telehealth Weight-Loss Drug Ads

In an era where telehealth services have become a lifeline for many seeking convenient medical solutions, a troubling trend has emerged in the marketing of weight-loss drugs, particularly compounded GLP-1 medications. A staggering 1,200 percent increase in questionable advertisements since just a

Bristol Myers Squibb's Iberdomide Shows Promise in Myeloma Trial
Research & Development Bristol Myers Squibb's Iberdomide Shows Promise in Myeloma Trial

Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in the realm of oncology and innovative technologies. With a deep understanding of the industry’s evolving landscape, Ivan offers unique insights

Telehealth Matches In-Person Care for Veterans with Diabetes
Tech & Innovation Telehealth Matches In-Person Care for Veterans with Diabetes

In an age where digital innovation is reshaping every facet of life, healthcare stands at the forefront of this transformation, particularly for managing chronic conditions like diabetes among older veterans. A pivotal study published in the Journal of General Internal Medicine this year reveals

Portable Gluten Detection Technology – Review
Research & Development Portable Gluten Detection Technology – Review

Imagine dining out with friends, eagerly awaiting a meal labeled "gluten-free," only to face the lingering fear of hidden gluten triggering severe health issues, a daily reality for millions with celiac disease or non-celiac gluten sensitivity. Cross-contamination and mislabeling remain pervasive

GOSH Unveils AI Strategy to Transform Pediatric Care
Tech & Innovation GOSH Unveils AI Strategy to Transform Pediatric Care

In an era where technology is reshaping every facet of healthcare, Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) in the UK stands at the forefront of a groundbreaking initiative to integrate artificial intelligence (AI) into pediatric care. This renowned institution, long

Sugary Drinks Fuel Colorectal Cancer Spread to Liver
Research & Development Sugary Drinks Fuel Colorectal Cancer Spread to Liver

Imagine reaching for a refreshing soda on a hot day, unaware that this simple choice might play a role in accelerating a deadly disease, as recent research has spotlighted a troubling link between sugary drinks and the spread of colorectal cancer to the liver, a leading cause of mortality among

How Is Japan Revolutionizing Clinical Trials with DCT Models?
Research & Development How Is Japan Revolutionizing Clinical Trials with DCT Models?

Japan stands as a pioneer in the transformation of clinical trials, embracing Decentralized Clinical Trial (DCT) models to reshape how medical research is conducted within its unique regulatory and cultural framework. At the core of this innovation lies the "partner site model," a strategic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later